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Assessing and managing nausea and vomiting in adults: At a glance 
Introduction 
Nausea and vomiting are unpleasant and potentially distressing symptoms that are commonly 
experienced by patients, especially for individuals on the perioperative care continuum, during 
pregnancy and childbirth, patients receiving chemotherapy and by patients in the advanced stages of a 
disease or at the end of life (Kelly and Ward, 2013; Vidall, 2014; Dye, 2017; Leach, 2019). Nausea 
and vomiting can also be a sign of more serious impairment, emotional distress or an adverse reaction 
to therapeutic treatments (Keeley, 2019). The potential impact of nausea and vomiting on the 
individuals’ wellbeing and quality of life can vary depending on the length and severity of the specific 
episodes, but in some cases can be so severe individuals may decide to stop treatment (Brooker and 
Waugh, 2013; Kelly and Ward, 2013). Prolonged nausea and vomiting can also result in physiological 
complications, psychological changes and social difficulties that could have short or long term impacts 
on health, with the most frequent and severe including dehydration, nutritional deficiencies and 
electrolyte and acid-base imbalance (see figure 1) (Brooker and Waugh, 2013; Patton and Thibodeau, 
2018).  
This article will: 
 Define nausea, retching and vomiting and outline common causes of these symptoms
 Provide an introduction to the anatomy and physiology associated with nausea and vomiting
 Provide awareness of how nausea and vomiting can impact on an individual’s life and what
complications and dangers are associated with vomiting
 Discuss how nausea and vomiting can be holistically assessed and managed
 Outline the uses, actions and side effects of antiemetic medications
Nausea and vomiting revised Click here to view linked References
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Terminology 
An understanding of medical terminologies associated with nausea and vomiting is important for 
reliable and effective assessment and management of patients’ symptoms (see figure 2) (Waugh and 
Grant, 2018). However, whilst this is vital when working collaboratively with other healthcare 
professionals, it also beneficial when communicating with patients, to have an awareness of some of 
the colloquial language that might be used to describe how they are feeling i.e. ‘barf’ and ‘hurl’ to 
accurately interpret their symptoms.  
Anatomy and physiology  
The act of emesis is associated with the initiation of the vomiting centre of the brain (Dougherty and 
Lister, 2015). This can be activated by a variety of receptors (i.e. histamines, acetylcholine, dopamine 
and 5-hydroxytryptamine) in the gastrointestinal tract, cerebral cortex, vestibular apparatus and 
chemoreceptor trigger zone, which respond to stimuli such as drugs and toxins, pain and fear, or 
movement and injury (Brookers and Waugh, 2013) (see figure 3 and figure 4). In some cases, the cause 
of nausea and vomiting and the specific aetiology may be multifactorial i.e. chemotherapy treatment, 
memory and anxiety as more than one type of receptor and pathway have initiated the vomiting centre 
(Collis, 2015).  
Assessment strategies 
Before nausea and vomiting can be treated or the cause reversed, there needs to be a comprehensive 
assessment of a patient’s symptoms and specific clinical features must be examined to find which 
branch of the emetic pathway has triggered the physiological response (Collis, 2015; Leach, 2019). To 
assess patients with emetic symptoms there are a variety of assessment tools/scales available to 
ascertain the severity or intensity of emetic symptoms. These can include numerical rating scales (often 
incorporated into analgesia infusion charts) and nausea, retching and vomiting questionnaires which 
are used to obtain more in-depth insight into the person’s emetic symptoms and their biopsychosocial 
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impact on the individual. However, whilst these tools are beneficial, a holistic patient assessment 
should also include a review of precipitating and relieving factors (i.e. movement, food/fluids, hunger, 
aromas), characteristics (i.e. duration, frequency),  as well as visual inspection of the vomit (i.e. 
volume, colour, odour, consistency and presence of blood) and if required physical examination (i.e. 
oral, rectal, abdominal, vital observations) (Dye, 2017; Keeley 2019).   
Assessments can also be undertaken in a preventative capacity, whereby the risk of developing nausea 
and vomiting are examined and calculated to prophylactically manage anticipatory nausea and 
vomiting (Dougherty and Lister, 2015). These risk assessments are not only beneficial for 
individualised patient assessments but have also been shown to allow for targeted management 
strategies, reducing the incidence of postoperative and chemotherapy-induced nausea and improving 
patient satisfaction (Vidall, 2014; Smith and Ruth-Sahd, 2015). Examples of factors which might be 
taken into account include age, gender, history of motion sickness, history of previous post-operative 
or chemotherapy-induced nausea and vomiting, smoking status, type and length of the surgical 
procedure and type of anaesthetic or analgesic agent (Dougherty and Lister, 2015; Smith and Ruth-
Sahd, 2015; Phillips and Perriman, 2017).    
Management strategies  
Effective management of nausea and vomiting not only influences a patient’s symptom response it 
also improves patient compliance with therapeutic treatments. However, as there is a vast array of 
management strategies that can be employed depending on the quality of the assessment and the 
resources available it is essential that healthcare professionals’ involve the patient in the decision 
process, and use a multimodal approach that incorporates both pharmacological and non-
pharmacological management methods (Collis, 2015; Dougherty & Lister 2015; Dye, 2017). 
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Pharmacological management 
The most common intervention used in today’s healthcare system is the administration of medication 
as it is often a safe and effective way of managing many signs and symptoms of diseases (NICE, 2015). 
Concerning the nausea and vomiting, antiemetics (anti-sickness) medication should only be prescribed 
when the specific cause of nausea and vomiting are known, as antiemetics vary in their mechanism(s) 
of action (see figure 6) depending upon the cause and which receptor has initiated the emetic response 
(British National Formulary, 2020). For example, an antiemetic medication that is effective in the 
management of chemotherapy-induced nausea and vomiting may have no role in the prevention and 
treatment of emetic symptoms due to other causes, e.g. motion sickness (Neal, 2012). Antiemetic 
medication can also be administered via multiple routes (i.e. intravascular, oral, rectal), therefore it is 
important to consider the most appropriate route of administration for each patient.  Additionally, as 
there may be more than one cause, individuals may require two or more antiemetics to achieve 
adequate symptom control (Dye, 2017).  
Non-pharmacological 
Although antiemetics are used worldwide to manage nausea and vomiting, pharmacological 
management is only partially effective and for some individuals can cause side effects (i.e. sedation, 
headache, constipation, and fatigue), therefore alternative strategies may also need to be employed 
(Lee and Fan, 2011; Yang, 2019).  
Acupressure 
Globally, acupressure has become a popular alternative therapy for reducing nausea and vomiting 
during chemotherapy, pregnancy and post-surgery (Byju, Pavithran & Antony, 2018; Yang, 2019).  It 
is a non-invasive therapeutic method, based on traditional Chinese medicine techniques associated 
with the application of physical gentle pressure to certain acupuncture points (acupoints) by finger, 
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elbow, hand or with various devices (Hofmann et al., 2017; Yang, 2019). Within Eastern philosophies, 
acupressure is believed to stimulate or disturb energy, thereby varying responses to negative stimuli 
(i.e. nausea and vomiting), whereas in western medical philosophies the focus of acupressure on the 
acupoints is on the triggered release of endogenous endorphins (Hofmann et al., 2017). Acupoints are 
located at specific places on imaginary lines ‘meridians’ throughout the human body (Byju, Pavithran 
& Antony, 2018) and acupressure of the P6 point (see figure 5) which lies 4cm proximal (three fingers) 
to the wrist crease of the dominant arm, has proven helpful to some patients in controlling nausea and 
vomiting, with, minimal side effects (Lee & Fan, 2011).  
Ginger 
Ginger is a herb belonging to the Zingiberaceae family and has been shown to block the actions of 
serotonin and acetylcholine which stimulate the vomiting reflex and trigger involuntary stomach 
contractions in the body (Lete & Allue, 2016; Stanisiere, Mousset and Lafay, 2018). Its use as an 
adjuvant therapy or as a complementary natural alternative for alleviating symptoms of nausea and 
vomiting (Tóth et al., 2018) has been researched extensively within pregnancy, chemotherapy, 
postoperative nausea and vomiting and motion sickness (Stanisiere, Mousset and Lafay, 2018) and it 
is now regarded as just as effective as pharmacological therapies, with fewer potential side effects 
(Lete & Allue, 2016).  
Nursing care 
As well as the use of complementary therapies, to ensure adequate holistic management, there are 
additional nursing considerations that need to be addressed when caring for patients who are 
experiencing nausea and vomiting (see figure 7) especially in relation to assisting patients with 
activities of living and biopsychosocial wellbeing.   
 Mouth care:  Following episodes of vomiting bile and acids from the stomach can cause
damage to teeth, gums, and throat or skin irritation around the mouth. To ensure the structures
and tissues of the mouth remain healthy it is essential to assist patients with oral mouth care
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and ensure they have access to equipment to perform oral hygiene (Burns, Cole & Stamford, 
2019). Removing the taste through oral hygiene can also help in reducing nausea (Nicol et al., 
2012).    
 Privacy and dignity: Close curtains to provide privacy and promote comfort by keeping
clothes clean and ensure that tissues and vomit bowls are easily accessible (Nicol et al., 2012;
NICE, 2016)
 Fluid balance: Vomiting and nausea can change a patient’s hydration status, putting them at
risk of dehydration. It is therefore important to keep an accurate fluid balance, if possible,
encourage oral intake or administer intravenous fluids (Dougherty & Lister, 2015).
 Environment: It is important to consider the stimulation of the vomiting centre following
episodes of vomiting via the cerebral cortex, as smells can trigger further episodes of nausea
and vomiting. To reduce the stimulus, strong odours should be avoided by moving the patients
or opening windows as fresh cool air can help alleviate symptoms of nausea (NICE, 2016).
 Diet and nutrition: Nausea and vomiting can lead to a reduction in appetite and/or cause a
patient to stop eating. Consequently, food charts should be used and patients should be
encouraged to eat small, frequent meals, consisting of bland, non-spicy, non-fatty foods (NICE,
2016).
Conclusion 
Pirri et al. (2013) state it is imperative that healthcare professional undertake multimodal approaches 
to assessment and management of nausea and all its associated symptoms, including preventative risk 
assessments and pharmacological as well as non-pharmacological treatments. However, this can only 
be achieved effectively and efficiently by working in partnership with the patient and ensuring that up-
to-date evidenced-based approaches are used to underpin decisions on which assessments to use, how 
risks are identified and what management strategies are employed (NMC, 2018).  
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Figure 1: The potential impact on nausea and vomiting on the individual 
(Brooker and Waugh, 2013; Patton and Thibodeau, 2018). 
Physical
•airway obstruction
•gastric aspiration and aspiration
pneumonia
•dehydration and electrolyte
imbalance
•metabolic alkalosis
•cardiovascular changes
•raised intracranial pressure
•hypovolaemic shock
•anorexia
•impaired nutritional status
•fatigue
•pain
•damage to wound integrity
•oesophageal damage
•dental decay
Psychological 
•embarrassment
•distress
•anxiety
•depression
•sense of loss of control
•altered body image
•low self esteem
Social
•difficulty communicating
•withdrawal
•social isolation
•stigma
•labelling
•impaired work and leisure
activities
•financial implications
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Figure 2: Medical terminology associated with nausea and vomiting 
(Roscoe, et al. 2011; Vidall, 2014; Dudley-Brown and Huether, 2013; Patton and Thibodeau, 2018; 
Waugh and Grant, 2018) 
•Subjective experience of feeling sick
•Unpleasant feeling often leading to vomiting
•Commonly associated with symptoms of hypersalivation and tachycardia
Nausea
•Movements associated with vomiting without the expulsion of
gastrointestinal contents
•Oftens begins with deep inspiration
Retching
•VomitingEmesis
•The forceful emptying of stomach contents through the mouth
•Usually associated with nausea and follows retchingVomiting
•Nausea, retching and vomiting
Emetic 
symptoms
•Ability of a treatment, e.g. chemotherapy, to cause nausea, retching and
vomiting
Emetogenic 
potential
•Medication used to treat nausea, retching and vomitingAntiemetics
•Spontaneous vomiting not preceded by nausea or retching
•Normally associated with direct neurological stimulation of the vomiting
centre of the brain i.e. brain tumour or gastrointestinal obstruction (pyloric
stenosis)
Projectile 
vomiting
•Acute nausea and vomiting (starting soon after the chemotherapy is given)
•Delayed nausea and vomiting (starting more than 24 hours after treatment)
Chemotherapy
-induced
nausea and 
vomiting 
•Unusual condition, where a person undergiong chemotherapy has emetic
symptoms to a conditioned stimulus before treatment is commenced e.g. the
chemotherapy nurse’s perfume.
Anticipatory 
nausea and 
vomiting
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Figure 3: The emetic pathway 
PLEASE INSERT PICTURE OF EMETIC PATHWAY 
Figure 4: Examples of stimuli and receptors 
(Collis, 2015; 
Figure 5: Pressure point – P6 
PLEASE INSERT IMAGE OR PICTURE OF PRESSURE POINT P6 
Vestibular system
Motion sickness
Base of skull
tumours
Histamine type 1
Acetylcholine
Chemoreceptor 
trigger zone
•Chemical
disturbances
•Opioids
•Chemotherapy
•Radiotherapy
•Anaesthetic
agents and
surgery
•Dopamine type 2
• Serotonin type 3
•Neurokinin 1
Gastrointestinal 
tract
•Gastric stasis
Tactile stimuli
Intramuscular
tension
Constipation
Handling of the
viscera during
surgery or
accumulation of
gas
Intestinal
obstruction
• Serotonin type 3
and 4
•Dopamine type 2
Acetylcholine
Cerebral cortex
•Pain
Fear
Anxiety
Raised
intracranial
pressure
Unpleasant sights
and odours
GABA
Histamine type 1
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Figure 6: Types of antiemetics and uses  
Types of antiemetics and 
examples of medications 
Uses 
Antihistamines 
 cinnarizine 
 cyclizine 
 promethazine 
Wide variety of uses, including motion sickness and vertigo. 
Phenothiazines and 
related drugs 
 perphenazine 
 prochlorperazine 
 trifluoperazine 
 chlorpromazine 
 levomepromazine 
 droperidol 
 haloperidol 
Phenothiazines are dopamine antagonists and act centrally by 
blocking the chemoreceptor trigger zone. 
 
Perphenazine, prochlorperazine and trifluoperazine are used in 
severe nausea and vomiting due to a variety of causes. Droperidol 
is used to prevent or treat nausea and vomiting following surgery. 
Haloperidol and levomepromazine are used in palliative care, 
and chlorpromazine is often prescribed as a last resort for patients 
who have a terminal illness. 
Domperidone and 
metoclopramide 
 
 
 
 
 
Metoclopramide hydrochloride is used to prevent postoperative 
nausea and vomiting and treat a variety of nausea and vomiting 
causes such as migraine and radiotherapy. It acts directly on the 
gastrointestinal tract, thus may be more beneficial then 
phenothiazine for nausea and vomiting associated with 
gastroduodenal, hepatic and biliary disease. Domperidone is used 
to treat emetic symptoms, with it acting at the chemoreceptor 
trigger zone. It has the advantage of being less likely to cause 
drowsiness and dystonic reactions because it does not readily cross 
the blood-brain barrier. 
5HT3-receptor antagonists 
 granisetron 
 ondansetron 
 palonosetron  
Therapy to prevent postoperative nausea and vomiting include 
5HT3-receptor antagonists. A combination of these medications 
can be used with choice based on the assessed risk of 
postoperative nausea and vomiting in each patient. 5HT3-
receptor antagonists are often used with Dexamethasone.   
Neurokinin 1-receptor 
antagonists 
 aprepitant 
 fosaprepitant 
Administered alongside 5HT3-receptor antagonist to prevent 
chemotherapy-induced nausea and vomiting. 
Nabilone Nabilone is a synthetic cannabinoid which can be considered as an 
add on for treating nausea and vomiting. Cannabinoids are used as 
a last resort when other antiemetics have failed to control nausea 
and vomiting due to chemotherapy.   
Hyoscine 
 
Hyoscine should be given to prevent motion sickness and should, 
therefore, be administered before vomiting has started.   
Dexamethasone A steroid used to manage nausea and vomiting during 
chemotherapy.   
(BNF, 2020) 
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Figure 7: Nursing considerations when caring for patients who are experiencing nausea and 
vomiting  
 
(Brooker and Waugh, 2013; Dye, 2017) 
Nurse in a safe position to 
protect the airway and 
remove dentures
Assist with mouth care and 
personal hygiene (change of 
clothes etc.) 
Use appropriate infection 
control measures
Maintain adequate 
ventilation and comfortable 
environmental temperature
Observe for signs of 
dehydration
Restrict or provide oral fluids 
and diet as instructed
Maintain an accurate fluid 
balance chart - meaure and 
assess vomit 
Administer antiemetics as 
prescribed, evaluate 
effectiveness and monitor for 
side effects
Provide vomit bowls and 
tissues and replace promptly 
when used 
Consider use of other 
strategies, e.g. acupressure, 
ginger, aromatherapy. 
Referral to another 
professional may be required 
e.g. clinical psychologist
Administer intravenous fluid 
and electrolytes as 
prescribed
Provide psychological 
support and education for 
the patient and family
Insert a nasogastric tube, if 
instructed
Identify any other strategies 
the patient finds helpful
Monitor observations, inform 
the doctor and request a 
review, as appropriate
Maintain privacy and dignity  
and provide physical comfort 
- hold vomit bowl and wipe 
mouth
Assit with the avoidance of 
food smells and strong 
odours
